Israel Englander Fulcrum Therapeutics, Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 150,867 shares of FULC stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,867

Previous 105,693 42.74%

Holding current value

$1.31 Million

Previous $727,000 80.88%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$6.34 - $8.84 $286,403 - $399,338	45,174 Added 42.74%	150,867 $1.32 Million
Q2 2025 Aug 14, 2025	BUY	$2.51 - $7.38 $163,152 - $479,707	65,001 Added 159.74%	105,693 $727,000
Q1 2025 May 15, 2025	SELL	$2.88 - $5.08 $102,041 - $179,989	-35,431 Reduced 46.54%	40,692 $117,000
Q4 2024 Feb 14, 2025	BUY	$2.97 - $4.84 $156,305 - $254,719	52,628 Added 224.0%	76,123 $357,000
Q3 2024 Nov 14, 2024	SELL	$3.18 - $9.74 $1.21 Million - $3.69 Million	-379,254 Reduced 94.17%	23,495 $83,000

Q2 2024 Aug 14, 2024	SELL	$5.98 - $9.31 $2.96 Million - $4.61 Million	-494,712 Reduced 55.12%	402,749 $2.5 Million
Q1 2024 May 15, 2024	BUY	$6.7 - $12.0 $3.08 Million - $5.52 Million	459,958 Added 105.13%	897,461 $8.47 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $436,785 - $942,248	-137,354 Reduced 23.89%	437,503 $2.95 Million
Q2 2023 Aug 14, 2023	SELL	$2.26 - $3.8 $103,286 - $173,667	-45,702 Reduced 7.36%	574,857 $1.9 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $1.76 Million - $8.68 Million	620,559 New	620,559 $1.77 Million
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $95,852 - $547,728	22,822 Added 39.1%	81,197 $398,000
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $578,648 - $1.18 Million	-41,332 Reduced 41.45%	58,375 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$7.28 - $30.97 $3.83 Million - $16.3 Million	-525,928 Reduced 84.06%	99,707 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$8.09 - $12.0 $247,343 - $366,888	30,574 Added 5.14%	625,635 $6.56 Million
Q1 2021 May 17, 2021	BUY	$10.94 - $15.32 $6.08 Million - $8.52 Million	556,199 Added 1431.22%	595,061 $7.01 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $304,678 - $520,750	38,862 New	38,862 $455,000
Q3 2020 Nov 16, 2020	SELL	$7.22 - $20.7 $338,957 - $971,802	-46,947 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$9.11 - $22.06 $1.26 Million - $3.05 Million	-138,072 Reduced 74.63%	46,947 $859,000
Q1 2020 May 14, 2020	BUY	$9.49 - $21.26 $900,012 - $2.02 Million	94,838 Added 105.16%	185,019 $2.21 Million
Q4 2019 Feb 14, 2020	SELL	$4.46 - $18.14 $985,164 - $4.01 Million	-220,889 Reduced 71.01%	90,181 $1.5 Million
Q3 2019 Nov 14, 2019	BUY	$6.64 - $14.89 $2.07 Million - $4.63 Million	311,070 New	311,070 $2.07 Million

Others Institutions Holding FULC

# of Institutions

133

Shares Held

55.4M

Call Options Held

176K

Put Options Held

13.5K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $451M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account